Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB18215InvestigationalSmall molecule
LP-184: Overview.
- Formula / weight
- C16H20N2O4 · 304.346 g/mol (avg)
- Also known as
- (R)-1-HYDROXY-1-((6'-HYDROXY-2',4',6'-TRIMETHYL-7'-OXO-6',7'-DIHYDROSPIRO(CYCLOPROPANE-1,5'-INDEN)-3'-YL)METHYL)UREA · Hydroxyurea methylacylfulvene · N-(((6'R)-6',7'-DIHYDRO-6'-HYDROXY-2',4',6'-TRIMETHYL-7'-OXOSPIRO(CYCLOPROPANE-1,5'-(5H)INDEN)-3'-YL)METHYL)-N-HYDROXYUREA · N-HYDROXY-N-(METHYLACYLFULVENE)UREA · UREA, N-(((6'R)-6',7'-DIHYDRO-6'-HYDROXY-2',4',6'-TRIMETHYL-7'-OXOSPIRO(CYCLOPROPANE-1,5'-(5H)INDEN)-3'-YL)METHYL)-N-HYDROXY-
- Code names
- LP-184
Resolves to
Structure
InChIKey
VWMPVAZEBAKLFR-HNNXBMFYSA-NSMILESCC1=C(CN(O)C(N)=O)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1What you can answer from here — as of July 09, 2026
Which companies are running trials of LP-184, in which indications and phases, and which of those programs are still active?